NO20025204D0 - Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner - Google Patents

Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner

Info

Publication number
NO20025204D0
NO20025204D0 NO20025204A NO20025204A NO20025204D0 NO 20025204 D0 NO20025204 D0 NO 20025204D0 NO 20025204 A NO20025204 A NO 20025204A NO 20025204 A NO20025204 A NO 20025204A NO 20025204 D0 NO20025204 D0 NO 20025204D0
Authority
NO
Norway
Prior art keywords
treating
compounds
methods
bacterial infections
preventing bacterial
Prior art date
Application number
NO20025204A
Other languages
English (en)
Other versions
NO20025204L (no
Inventor
R John Collier
Bret R Sellman
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of NO20025204D0 publication Critical patent/NO20025204D0/no
Publication of NO20025204L publication Critical patent/NO20025204L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20025204A 2000-05-04 2002-10-30 Forbindelser og fremgangsmåter for behandling og forebygging av bakteriellinfeksjon NO20025204L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20180000P 2000-05-04 2000-05-04
PCT/US2001/014372 WO2001082788A2 (en) 2000-05-04 2001-05-04 Compounds and methods for the treatment and prevention of bacterial infection

Publications (2)

Publication Number Publication Date
NO20025204D0 true NO20025204D0 (no) 2002-10-30
NO20025204L NO20025204L (no) 2002-12-16

Family

ID=22747352

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025204A NO20025204L (no) 2000-05-04 2002-10-30 Forbindelser og fremgangsmåter for behandling og forebygging av bakteriellinfeksjon

Country Status (15)

Country Link
US (1) US7037503B2 (no)
EP (1) EP1278764A4 (no)
JP (1) JP2003531841A (no)
KR (1) KR20030019366A (no)
CN (1) CN1440419A (no)
AU (1) AU2001261171A1 (no)
CA (1) CA2407443A1 (no)
CZ (1) CZ20023662A3 (no)
HU (1) HUP0301658A2 (no)
IL (1) IL152553A0 (no)
MX (1) MXPA02010826A (no)
NO (1) NO20025204L (no)
PL (1) PL365453A1 (no)
WO (1) WO2001082788A2 (no)
ZA (1) ZA200208835B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455673B1 (en) * 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
DE60128008T2 (de) * 2000-12-05 2008-01-10 Wisconsin Alumni Research Foundation, Madison Rezeptor für ein toxin aus bacillus anthracis
US7763451B2 (en) 2001-11-09 2010-07-27 The United States Of America As Represented By The Department Of Health And Human Services Methods for preparing Bacillus anthracis protective antigen for use in vaccines
AU2002242935A1 (en) * 2001-12-05 2003-06-17 Rakesh Bhatnagar A process for the preparation of a non-toxic anthrax vaccine
EP1572903A2 (en) * 2002-02-11 2005-09-14 Alexion Pharmaceuticals, Inc. Immunotherapeutics for biodefense
US20040258699A1 (en) * 2002-02-11 2004-12-23 Bowdish Katherine S. Immunotherapeutics for biodefense
US7201912B2 (en) * 2002-04-12 2007-04-10 Emergent Biodefense Operation Lansing Inc. Recombinant immunogenic compositions and methods for protecting against lethal infections from Bacillus anthracis
AU2003256289A1 (en) * 2002-06-26 2004-01-19 Human Genome Sciences, Inc. Modified shine-dalgarno sequences and methods of use thereof
US7601351B1 (en) 2002-06-26 2009-10-13 Human Genome Sciences, Inc. Antibodies against protective antigen
EP1575505A4 (en) * 2002-09-10 2007-01-24 Vical Inc CODON OPTIMIZATION-BASED POLYNUCLEOTIDE VACCINES AGAINST BACILLUS ANTHRACIS INFECTION
WO2005004791A2 (en) * 2002-11-08 2005-01-20 President And Fellows Of Harvard College Compounds and methods for the treatment and prevention of bacterial infection
US20050130892A1 (en) * 2003-03-07 2005-06-16 Xencor, Inc. BAFF variants and methods thereof
US20060014248A1 (en) * 2003-01-06 2006-01-19 Xencor, Inc. TNF super family members with altered immunogenicity
US7553930B2 (en) * 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
US20050221443A1 (en) * 2003-01-06 2005-10-06 Xencor, Inc. Tumor necrosis factor super family agonists
WO2004110481A2 (en) * 2003-02-06 2004-12-23 Cerus Corporation Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
EP1592442A2 (en) * 2003-02-06 2005-11-09 Cerus Corporation Modified free-living microbes, vaccine compositions and methods of use thereof
US7695725B2 (en) * 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
US7842289B2 (en) * 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
US20100003276A1 (en) * 2004-12-07 2010-01-07 Hermes Jeffery D Methods for treating anthrax and inhibiting lethal factor
US20080206276A1 (en) * 2005-07-08 2008-08-28 Michael Otto Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections
EP2021021A2 (en) * 2006-05-12 2009-02-11 Oklahoma Medical Research Foundation Anthrax compositions and methods of use and production
WO2009126355A2 (en) * 2008-01-28 2009-10-15 Baxter International, Inc. Methods of increasing recombinant production of bacillus anthracis protective antigen
US20110110968A1 (en) * 2009-11-12 2011-05-12 Stanley Goldman Human optimized Bacillus anthracis protective antigen
RU2592686C2 (ru) 2011-04-22 2016-07-27 ВАЙЕТ ЭлЭлСи Композиции, относящиеся к мутантному токсину clostridium difficile, и способы их применения
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792458A (en) * 1987-10-05 1998-08-11 The United States Of America As Represented By The Department Of Health And Human Services Mutant diphtheria toxin conjugates
US5677274A (en) * 1993-02-12 1997-10-14 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services Anthrax toxin fusion proteins and related methods
US5591631A (en) 1993-02-12 1997-01-07 The United States Of America As Represented By The Department Of Health And Human Services Anthrax toxin fusion proteins, nucleic acid encoding same
US5917017A (en) * 1994-06-08 1999-06-29 President And Fellows Of Harvard College Diphtheria toxin vaccines bearing a mutated R domain
US6455673B1 (en) * 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
WO1997023236A1 (en) 1995-12-13 1997-07-03 President And Fellows Of Harvard College Use of toxin peptides and/or affinity handles for the delivering compounds into cells
GB9618107D0 (en) * 1996-08-30 1996-10-09 Secr Defence Vaccine production
AU2771099A (en) 1998-02-18 1999-09-06 President And Fellows Of Harvard College Inhibition of toxin translocation
US6426231B1 (en) * 1998-11-18 2002-07-30 The Texas A&M University System Analyte sensing mediated by adapter/carrier molecules
US6413768B1 (en) * 1998-12-02 2002-07-02 University Of Maryland Expression plasmids
US6329156B1 (en) * 1999-03-22 2001-12-11 The Regents Of The University Of California Method for screening inhibitors of the toxicity of Bacillus anthracis

Also Published As

Publication number Publication date
CA2407443A1 (en) 2001-11-08
ZA200208835B (en) 2004-02-09
NO20025204L (no) 2002-12-16
WO2001082788A9 (en) 2002-12-19
EP1278764A2 (en) 2003-01-29
HUP0301658A2 (hu) 2003-08-28
CN1440419A (zh) 2003-09-03
PL365453A1 (en) 2005-01-10
WO2001082788A2 (en) 2001-11-08
AU2001261171A1 (en) 2001-11-12
US20020039588A1 (en) 2002-04-04
IL152553A0 (en) 2003-05-29
EP1278764A4 (en) 2004-05-19
JP2003531841A (ja) 2003-10-28
CZ20023662A3 (cs) 2003-04-16
US7037503B2 (en) 2006-05-02
WO2001082788A3 (en) 2002-07-25
MXPA02010826A (es) 2006-03-09
KR20030019366A (ko) 2003-03-06

Similar Documents

Publication Publication Date Title
NO20025204D0 (no) Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner
DK1341769T3 (da) Bakterielle gyrase-inhibitorer og anvendelser deraf
DE60139930D1 (de) Desinfizieruns- und desodorierungsverfahren
NO20011964L (no) Brönnbehandlingsfluider og fremgangsmåter for anvendelse derav
DK1335678T3 (da) Oralt behandlingssystem
DE60028849D1 (de) Sterilisationsmethode
WO2003088897A3 (en) Fab i inhibitors
AU2003290867A8 (en) Methods and products for treating staphylococcal infections
DK1339292T3 (da) Sammensætning og fremgangsmåde
NO20014314L (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
NO20024201D0 (no) Substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-on og anvendelse derav for hemning av hormonsensitiv lipase
IL155484A0 (en) Method and system for dynamically maintaining internet associations
DK1322597T3 (da) Fremgangsmåde og intermediære
NO20032122L (no) Forbedret behandling
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
NO984949D0 (no) Carbapenem-antibakterielle forbindelser, preparater inneholdende slike forbindelser og behandlingsmetoder
NO20023737D0 (no) Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse
DE60216377D1 (de) Sublimationssystem und -verfahren
DE60140597D1 (de) Vakuumbehandlungsverfahren
NO20032769L (no) Kombinasjonsmetode for behandling av virale infeksjoner
DE60125241D1 (de) Wärmebehandlungseinrichtung
AU2002334761A1 (en) Methods of treating drug-resistant bacterial infections
AU2001258675A1 (en) Treating infections
IS6626A (is) Kristallskenndur meðferðarmiðill
AU2003290506A8 (en) Methods and devices for treating severe peripheral bacterial infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application